- Previous Close
0.0000 - Open
0.0021 - Bid --
- Ask --
- Day's Range
0.0021 - 0.0021 - 52 Week Range
0.0020 - 0.0021 - Volume
1,280 - Avg. Volume
6 - Market Cap (intraday)
338,820 - Beta (5Y Monthly) -0.63
- PE Ratio (TTM)
∞ - EPS (TTM)
0.0000 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Amexdrug Corporation, a pharmaceutical and cosmeceutical company, through its subsidiaries, primarily distributes pharmaceutical products. It is also involved in the research, development, manufacture, and sale of pharmaceutical drugs, cosmetics, and medical devices. The company operates in two segments, Distribution and Health and Beauty Products. In addition, it engages in the distribution of prescription and over-the-counter drugs, non-drug products, and health and beauty products; and private manufacturing and labeling activities. Further, the company manufactures and sells facial and body creams, arthritic pain relief medications, and hair and nail care products to pharmacies, beauty salons, beauty supply stores, and other fine shops. Amexdrug Corporation markets its products under the Sponix name. The company distributes its products through its subsidiaries primarily to independent pharmacies and secondarily to small-sized pharmacy chains, alternative care facilities, and other wholesalers and retailers in the state of California. The company was formerly known as Harlyn Products, Inc. and changed its name to Amexdrug Corporation in April 2000 to reflect the change in its business to the sale of pharmaceutical products. Amexdrug Corporation was founded in 1963 and is based in Commerce, California.
www.amexdrug.com9
Full Time Employees
December 31
Fiscal Year Ends
Sector
Recent News: AXRX
View MorePerformance Overview: AXRX
Trailing total returns as of 4/15/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: AXRX
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: AXRX
View MoreValuation Measures
Market Cap
338.82k
Enterprise Value
338.82k
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
1.81%
Return on Assets (ttm)
11.25%
Return on Equity (ttm)
28.78%
Revenue (ttm)
9.17M
Net Income Avi to Common (ttm)
165.83k
Diluted EPS (ttm)
0.0000
Balance Sheet and Cash Flow
Total Cash (mrq)
168.01k
Total Debt/Equity (mrq)
146.01%
Levered Free Cash Flow (ttm)
-529.47k